Breathe Well Live Well
|
N30 Pharma Announces FDA Approval to Initiate Phase 1 Clinical Trial for First …
PR Newswire (press release) It is the lead product in N30 Pharma's portfolio of drugs which are designed to treat asthma, COPD and IBD. N6022 will initially be tested using intravenous … |
View full post on asthma – Google News
|
Teva Respiratory Announces Positive Results From Phase III Trial of BDP HFA …
PR Newswire (press release) While AR itself is not life-threatening (unless accompanied by severe asthma or anaphylaxis), morbidity associated with the condition can be significant. … |
View full post on asthma – Google News
|
BreathSlim, Inc. Launches Next-Generation System for Advancement in Weight Loss
PR Newswire (press release) While weight loss goals may be different based on individual needs, the strong correlation between individuals with breathing problems, risk of asthma, … |
View full post on asthma – Google News
|
Allergy and Asthma Associates Selects ITelagen for Hosting and Management of EHR
PR Newswire (press release) With adoption of EHR, Allergy and Asthma Associates want to focus on delivering healthcare while leaving the information technology management to the … |
View full post on asthma – Google News